Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SAFEGUARD SCIENTIFICS INC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
General and administrative
19
17.6
18.7
17.1
16.9
9.98
9.47
7.15
4.78
5.68
Operating income
-19
-17.6
-18.7
-17.1
-16.9
-9.98
-9.47
-7.15
-4.78
-5.68
Interest expense
4.4
4.52
4.63
8.62
16.1
14
0
Interest income
1.9
1.94
2.08
3.88
2.81
2.04
0.26
0.28
0.79
0.9
Other non-operating income
31.7
0.22
-1.68
-0.34
-5.16
12.3
-7.71
22
-3.3
2.04
Pre-tax income
-5.15
-59.5
-22.3
-88.6
-15.6
54.6
-37.6
27
-14.3
-9.83
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-5.15
-59.5
-22.3
-88.6
-15.6
54.6
-37.6
27
-14.3
-9.83
EBITDA
-18.9
-17.4
-18.4
-16.8
-16.2
-9.17
-9.47
EPS, basic
-0.25
-2.85
-1.09
-4.34
-0.76
2.64
-1.81
1.36
-0.87
-0.61
EPS, diluted
-0.25
-2.85
-1.09
-4.34
-0.76
2.64
-1.81
1.36
-0.87
-0.61
Shares, basic (weighted)
21
20.9
20.3
20.4
20.5
20.6
20.8
19.8
16.3
16.2
Shares, diluted (weighted)
21
20.9
20.3
20.4
20.5
20.6
20.8
19.8
16.3
16.2
Balance sheet
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Cash and equivalents
112
32.8
22.1
20.8
7.7
25
15.6
24.7
13.3
9.5
Short-term investments
0
5.96
0
Other current assets
1.68
5.81
2.11
4.64
0.58
1.3
0.46
0.97
1.25
0.39
Total current assets
139
69.7
32.6
33.6
46.7
26.4
16.1
30.3
21.4
9.91
Property, plant and equipment
0.12
2.15
1.87
1.51
0.81
2.1
1.79
Lease right-of-use assets
1.79
1.56
1.29
0.97
Other non-current assets
2.08
1.04
0.3
0.32
2.61
2
0.78
0.22
0.43
0.26
Total assets
318
257
232
176
146
108
69
54
37.7
22.8
Accounts payable
0.23
0.29
0.14
0.16
0.17
0.04
0.06
0.04
0.02
0.11
Accrued liabilities
2.33
2.79
2.22
1.85
2.18
0.63
0.41
0.52
0.87
0.6
Short-term debt
0
40.5
0
Total current liabilities
6.56
6.42
5.86
45.8
32.9
2.43
3.47
1.73
1.82
2.05
Lease liabilities
2.38
2.05
1.68
1.25
0.76
Other non-current liabilities
3.51
3.97
3.63
3.54
2.8
1.03
0.64
0.05
0.05
0.05
Total liabilities
60.6
61.3
62.1
94.7
78.8
5.84
6.16
3.46
3.12
2.86
Total debt
0
40.5
68.6
Paid-in capital
820
817
816
813
811
811
808
807
805
794
Retained earnings
-545
-604
-627
-715
-731
-697
-737
-710
-724
-734
Treasury stock
-19.3
-19.6
-21.1
-17.3
-15
-14
-10.2
-48.6
-48.4
-42.4
Other comprehensive income
0
-0.25
-0.43
-0.11
0
-0.03
-0.03
-0.03
-0.03
-0.03
Total equity
258
196
170
81.8
67
102
62.9
50.6
34.6
20
Total liabilities and equity
318
257
232
176
146
108
69
54
37.7
22.8
Shares outstanding
21.6
21.6
21.6
Cash flow statement
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Net income
-5.15
-59.5
-22.3
-88.6
-15.6
54.6
-37.6
27
-14.3
-9.83
Depreciation and amortization
0.07
0.19
0.33
0.32
0.69
0.81
0
Stock-based compensation
1.94
1.61
2.39
1.14
0.97
1.24
0.97
1.78
1.45
1.12
Change in receivables
-0.37
-0.92
-1.52
-3.56
-2.07
-0.82
Cash from operations
-20.2
-17.7
-18.7
-20.8
-26
-20
-8.14
-8.15
-3.26
-3.31
Capital expenditures
-0.06
-1.86
-0.43
0
Purchases of investments
0
-11.9
-8.53
Cash from investing
17
-57
20.1
-10.1
32.1
126
-1.27
58.1
-4.66
5.72
Stock issued
1.29
0.68
0.01
-0
Share buybacks
-25
-5
-5.39
0
0
-40.7
-2.94
-0.08
Dividends paid
0
-20.7
0
0
-5.82
Cash from financing
-24.2
-4.32
-5.84
29.6
-25
-89.5
-0.04
-40.8
-3.49
-6.25
Net change in cash
-27.4
-79.1
-4.44
-1.31
-18.9
16.9
-9.45
9.16
-11.4
-3.84
Free cash flow
-20.2
-19.6
-19.1
-20.8
Interest paid
2.9
2.9
5
5
11.1
11.5
0
Income taxes paid
0
0
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2023. Valuation uses the share price of $0.47 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-32.5%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Total assets growth, 1y
-39.4%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-30.8%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-31.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
-0.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
-7.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-4.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.84x
Current assets / current liabilities.
Quick ratio
4.64x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
4.64x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
12.5%
Total liabilities / total assets.
Working capital
$7.9M
Current assets - current liabilities.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.61
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.61
Net income per basic share, as reported (split-adjusted).
Market cap + total debt - cash - short-term investments.
Earnings yield
-125.3%
Net income / market cap (the inverse of P/E).
Dividend yield
74.2%
Dividends paid over the period / market cap.
Shareholder yield
75.1%
(Dividends paid + share buybacks) / market cap.
Was SAFEGUARD SCIENTIFICS INC profitable in fiscal 2023?
No. It reported a net loss of $9.8M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.